Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by mjh9413on Mar 18, 2022 2:05am
165 Views
Post# 34524257

RE:RE:Squeeze

RE:RE:Squeeze Iscfa what numbers of clients each qtr and year end are going to make up $40MM net revs in 2022?  Seriously do you believe we are going to see $40MM 2022 fy?   I take it you mean july 2022 to june 2023fy, not jan 2022 to dec 2022 calendar year.
And that EBITDA margin. We currently have no experience of what these margins might be but recent financials show prospectively (on very limited rev experience) gross margins alone (after COGS) might be anywhere between 26 and 50% with the latter arising on significant proportion of hardware sales. Makes the EBITDA magin percent you use highly suspect.
Cannot see tax being payable with the accumulated losses to date.
And then we have the share count! The number you use is dec 31st fully diluted but they are going to continue issuing additional options and share-based payments. What I do find intriguing is thet the two exercises of options post-Dec 31st were mainly options with average price of 87cents with a small number at 30c. The 80c+ ones would have a pretty long, multi-year expiry date according to the table of outstandings except therre are many million granted to consultants and I might speculatethese wereinvolved. .Wonder if they were being sold in that dec to end of feb period before the financials came out. But truly that is neither here ot there except for fact all grants seem to vest IMMEDIATELY, MOST PECULIAR FOR INCENTIVE! OPTIONS, and as with most companies, none are issued at a premium to sp on grant date...some incentive.
Finally we are seeing a significant and high proportion of receivables accumulate without ANY data on their aging. This, to me, is a red rag to a bull.
Look forward to more data on the numbers you crunched.
ps NO. a negative ebitda does not EVER mean a negative share price (dah!) but a multiple can and is able to applied to a positive ebitda. A negative ebitda is viewed in financial performance terms by positive changes being made in it relative to growth of revs and changes in other ratios.
<< Previous
Bullboard Posts
Next >>